HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frank Li Selected Research

AMG-837

1/2011AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frank Li Research Topics

Disease

5Nemaline Myopathies (Nemaline Myopathy)
01/2020 - 09/2015
4Burns
01/2018 - 12/2010
2Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2021
2Muscular Diseases (Myopathy)
01/2020 - 01/2019
2Hypertrophy
01/2020 - 01/2019
2Type 2 Diabetes Mellitus (MODY)
01/2012 - 01/2011
1Disease Progression
01/2020
1Muscle Weakness
01/2020
1Wounds and Injuries (Trauma)
01/2019
1Cicatrix (Scar)
05/2017
1Hypoglycemia (Reactive Hypoglycemia)
09/2012
1Rupture
08/2012
1Hyperglycemia
01/2012
1Insulin Resistance
01/2012

Drug/Important Bio-Agent (IBA)

4nebulinIBA
01/2020 - 09/2015
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2019
1Protein Isoforms (Isoforms)IBA
01/2020
1ConnectinIBA
01/2020
1Myosins (Myosin)IBA
01/2020
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2019
1Glutathione Transferase (Glutathione S-Transferase)IBA
01/2019
1Nonsense Codon (Nonsense Mutation)IBA
10/2016
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2012
1dipalmitoylphosphatidylserineIBA
08/2012
1CalciumIBA
08/2012
1LipidsIBA
08/2012
1Streptozocin (Streptozotocin)FDA Link
01/2012
1IncretinsIBA
01/2012
1Glucose (Dextrose)FDA LinkGeneric
01/2012
1Glucagon-Like Peptide-1 ReceptorIBA
01/2012
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2012
1AMG-837IBA
01/2011

Therapy/Procedure

2Length of Stay
01/2018 - 12/2010
1Gas Lasers
05/2017
1Therapeutics
04/2013